Chemoinformaics analysis of 2,5,9-Trimethylcycloundeca-4,8-dienone
| Molecular Weight | 206.329 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 12 |
| Exact Molecular Weight | 206.167 | nRing | 1 |
| Solubility: LogS | -4.147 | nHRing | 0 |
| Solubility: LogP | 3.122 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.8514 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.546 |
| Synth | 3.794 |
| Natural Product Likeliness | 2.229 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.284 |
| Pgp-sub | 0.004 |
| HIA | 0.045 |
| CACO-2 | -4.572 |
| MDCK | 0.0000232 |
| BBB | 0.742 |
| PPB | 0.949118 |
| VDSS | 0.786 |
| FU | 0.0139643 |
| CYP1A2-inh | 0.395 |
| CYP1A2-sub | 0.597 |
| CYP2c19-inh | 0.213 |
| CYP2c19-sub | 0.333 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.902 |
| CYP2d6-inh | 0.102 |
| CYP2d6-sub | 0.792 |
| CYP3a4-inh | 0.134 |
| CYP3a4-sub | 0.197 |
| CL | 6.515 |
| T12 | 0.796 |
| hERG | 0.006 |
| Ames | 0.003 |
| ROA | 0.005 |
| SkinSen | 0.892 |
| Carcinogencity | 0.035 |
| EI | 0.804 |
| Respiratory | 0.04 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.715995 |